Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr 6;77(13):1656-1659.
doi: 10.1016/j.jacc.2021.02.024.

ACHD-Specific Risk Factors for Severe COVID-19

Elisa A Bradley  1 , Omer Cavus  2
Affiliations
Editorial

ACHD-Specific Risk Factors for Severe COVID-19

Elisa A Bradley et al. J Am Coll Cardiol. .
No abstract available

Keywords: COVID-19; adult congenital heart disease; adverse outcomes.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr. Bradley is supported by National Institutes of Health (grant HL148701). Dr. Cavus has reported that he has no relationships relevant to the contents of this paper to disclose.

Figures

FIGURE 1
FIGURE 1. Risk Factors for Severe COVID-19 in Patients With ACHD
To assess risk factors for severe coronavirus disease-2019 (COVID-19) in adults with congenital heart disease (ACHD), it is important to evaluate non-ACHD risk factors as set forth by organizations such as the United States Centers for Disease Control and Prevention, as well as ACHD-associated risk factors (i.e., physiological stages C and D). In this study, new ACHD-specific risk factors (red box) are identified and should be considered when performing an overall assessment of individual risk for severe disease. *Heart conditions such as heart failure, coronary artery disease, or cardiomyopathies. BMI = body mass index; NYHA = New York Heart Association; O2 = oxygen.
See this image and copyright information in PMC

Comment on

  • COVID-19 in Adults With Congenital Heart Disease.
    Broberg CS, Kovacs AH, Sadeghi S, Rosenbaum MS, Lewis MJ, Carazo MR, Rodriguez FH 3rd, Halpern DG, Feinberg J, Galilea FA, Baraona F, Cedars AM, Ko JM, Porayette P, Maldonado J, Sarubbi B, Fusco F, Frogoudaki AA, Nir A, Chaudhry A, John AS, Karbassi A, Hoskoppal AK, Frischhertz BP, Hendrickson B, Bouma BJ, Rodriguez-Monserrate CP, Broda CR, Tobler D, Gregg D, Martinez-Quintana E, Yeung E, Krieger EV, Ruperti-Repilado FJ, Giannakoulas G, Lui GK, Ephrem G, Singh HS, Almeneisi HM, Bartlett HL, Lindsay I, Grewal J, Nicolarsen J, Araujo JJ, Cramer JW, Bouchardy J, Al Najashi K, Ryan K, Alshawabkeh L, Andrade L, Ladouceur M, Schwerzmann M, Greutmann M, Meras P, Ferrero P, Dehghani P, Tung PP, Garcia-Orta R, Tompkins RO, Gendi SM, Cohen S, Klewer S, Hascoet S, Mohammadzadeh S, Upadhyay S, Fisher SD, Cook S, Cotts TB, Aboulhosn JA. Broberg CS, et al. J Am Coll Cardiol. 2021 Apr 6;77(13):1644-1655. doi: 10.1016/j.jacc.2021.02.023. J Am Coll Cardiol. 2021. PMID: 33795039 Free PMC article.

References

    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506. - PMC - PubMed
    1. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 2020;5:831–40. - PubMed
    1. Peng YD, Meng K, Guan HQ, et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi 2020;48:450–5. - PubMed
    1. Rehan R, Kotchetkova I, Cordina R, Celermajer D. Adult congenital heart disease survivors at age 50 years: medical and psychosocial status. Heart Lung Circ 2021;30:261–6. - PubMed
    1. Lewis MJ, Anderson BR, Fremed M, et al. Impact of coronavirus disease 2019 (COVID-19) on patients with congenital heart disease across the lifespan: the experience of an academic congenital heart disease center in New York City. J Am Heart Assoc 2020;9:e017580. - PMC - PubMed